Sale!

1 3-BETA-D-GLUCAN BDG Test

2,360 د.إ

-10%

The 1,3-Beta-D-Glucan (BDG) Test is a diagnostic tool used to detect invasive fungal infections, including those caused by Candida, Aspergillus, and certain other types of fungi. This test measures the levels of 1,3-beta-D-glucan, a component of the cell walls of many fungi, in the blood. Elevated levels can indicate a fungal infection, making this test particularly useful in clinical settings for patients with symptoms of invasive fungal infections or for those at high risk, such as individuals with weakened immune systems.

In the United Arab Emirates, DNA Labs UAE offers the 1,3-Beta-D-Glucan Test at a cost of 2360 AED. DNA Labs UAE is known for its state-of-the-art facilities and commitment to providing accurate and reliable diagnostic services. The test is conducted in a controlled laboratory environment by experienced professionals, ensuring high-quality results. Patients or healthcare providers interested in utilizing this test can contact DNA Labs UAE for more information on scheduling and preparation requirements.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

1 3-BETA-D-GLUCAN BDG Test

Components: 2 mL (1 mL min.) serum from 1 Red Top (No additive) tube preferably Glucan free OR 2 mL (1 mL min.) BAL fluid in a sterile screw capped container OR 1 mL (0.5 mL min.) CSF in a sterile screw capped container. Ship refrigerated or frozen.

Price: 2360.0 AED

Report Delivery: 1 week

Method: Spectrophotometry

Test Type: Infections

Doctor: Physician, Oncologist

Test Department: DNA Labs UAE

Pre Test Information: No special preparation required

Test Details

The (1 3)-BETA-D-GLUCAN (BDG) test is a diagnostic test used to detect the presence of fungal infections in the body. Beta-D-glucan is a polysaccharide found in the cell walls of many fungi, including Candida species and Aspergillus species.

The BDG test involves taking a blood sample from the patient and measuring the levels of beta-D-glucan in the sample. Elevated levels of beta-D-glucan indicate the presence of fungal infection. This test is particularly useful in diagnosing invasive fungal infections, which can be difficult to detect using other methods.

The BDG test is often used in conjunction with other diagnostic tests, such as cultures or imaging studies, to confirm the presence of fungal infection. It is commonly used in patients with compromised immune systems, such as those undergoing chemotherapy or organ transplantation.

It is important to note that the BDG test is not specific to any particular type of fungal infection and cannot identify the specific fungal species causing the infection. Therefore, it is typically used as a screening tool rather than a definitive diagnostic test.

Test Name 1 3-BETA-D-GLUCAN BDG Test
Components
Price 2360.0 AED
Sample Condition 2 mL (1 mL min.) serum from 1 Red Top (No additive) tube preferably Glucan free OR 2 mL (1 mL min.) BAL fluid in a sterile screw capped container OR 1 mL (0.5 mL min.) CSF in a sterile screw capped container. Ship refrigerated or frozen.
Report Delivery 1 week
Method Spectrophotometry
Test type Infections
Doctor Physician, Oncologist
Test Department:
Pre Test Information No special preparation required
Test Details

The (1 3)-BETA-D-GLUCAN (BDG) test is a diagnostic test used to detect the presence of fungal infections in the body. Beta-D-glucan is a polysaccharide found in the cell walls of many fungi, including Candida species and Aspergillus species.

The BDG test involves taking a blood sample from the patient and measuring the levels of beta-D-glucan in the sample. Elevated levels of beta-D-glucan indicate the presence of fungal infection. This test is particularly useful in diagnosing invasive fungal infections, which can be difficult to detect using other methods.

The BDG test is often used in conjunction with other diagnostic tests, such as cultures or imaging studies, to confirm the presence of fungal infection. It is commonly used in patients with compromised immune systems, such as those undergoing chemotherapy or organ transplantation.

It is important to note that the BDG test is not specific to any particular type of fungal infection and cannot identify the specific fungal species causing the infection. Therefore, it is typically used as a screening tool rather than a definitive diagnostic test.